Patent Assignment
Reel/Frame 036887/0324
Change of Name
Recorded: 2015-10-19
Pages: 13
Assignor
COM AFFILIATION, INC.
Executed: 2015-09-09
Assignee
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
1300 MORRIS PARK AVENUE, BRONX, NEW YORK, 10461
Covered Properties
(20)
Nucleic Acid Encoding Rhodococcus Phenylalanine Dehydrogenase
Patent:
5,851,810 →
Application:
08/461,990 →
Recombinant Mycobacteria
Patent:
5,854,055 →
Application:
08/463,942 →
Peptides Which Bind to Anti-Double Stranded Dna Antibody
Patent:
6,001,964 →
Application:
08/531,832 →
Thyroid Sodium/Iodide Symporter and Nucleic Acid Encoding Same
Patent:
6,391,579 →
Application:
08/595,553 →
Rep-Max Protein Having Anti-Oncogenic Activity and Uses Thereof
Patent:
5,811,298 →
Application:
08/609,046 →
Polycystic Kidney Disease PKD2 Gene and Uses Thereof
Patent:
6,031,088 →
Application:
08/651,999 →
Method and Compounds for Inhibiting Lipid Biosynthesis of Bacteria and Plants
Patent:
5,837,480 →
Application:
08/700,306 →
Mycobacterial Species-Specific Reporter Mycobacteriophages
Patent:
6,300,061 →
Application:
08/705,557 →
Human Prostaglandin Transporter
Patent:
5,792,851 →
Application:
08/706,936 →
Novel Hemoglobin Crosslinkers
Patent:
5,750,725 →
Application:
08/720,250 →
Pancreatic Beta Cells for Allogeneic Transplantation Without Immunosuppression
Patent:
6,156,306 →
Application:
08/732,155 →
Methods and Compositions for Transforming Cells
Patent:
5,928,914 →
Application:
08/743,796 →
Method for Detecting Hemolysis
Recombinant Mycobacteria Auxotrophic for Diaminopimelate
Patent:
6,221,364 →
Application:
08/747,177 →
Gene Therapy for Alleviating Erectile Dysfunction
Patent:
6,150,338 →
Application:
08/799,144 →
Vector Constructs for the Selection and Identification of Open Reading Frames
Patent:
5,981,182 →
Application:
08/816,721 →
Embcab Operon of Mycobacteria and Mutants Thereof
Patent:
6,015,890 →
Application:
08/822,586 →
Peptides for the Treatment and Diagnosis of Systemic Lupus Erythematosus
Patent:
6,932,970 →
Application:
08/833,838 →
TM4 Conditional Shuttle Phasmids and Uses Thereof
Patent:
5,972,700 →
Application:
08/938,059 →
Inhibitors of Nucleoside Metabolism
Patent:
5,985,848 →
Application:
08/949,388 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License
Sep 5, 2012
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028914/0437 →
Change of Name
Feb 26, 2015
From: INDUSTRIAL RESEARCH LIMITED
To: CALLAGHAN INNOVATION RESEARCH LIMITED
Reel/Frame 035101/0436 →
Assignment of Assignor's Interest
Mar 4, 2015
From: CALLAGHAN INNOVATION RESEARCH LIMITED
To: VICTORIA LINK LIMITED
Reel/Frame 035086/0004 →
Confirmatory License
Jun 22, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035985/0781 →
Assignment of Assignor's Interest
Oct 13, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036851/0385 →
Assignment of Assignor's Interest
Oct 16, 2015
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: COM AFFILIATION, INC.
Reel/Frame 036877/0885 →
Change of Name
Oct 20, 2015
From: COM AFFILIATION, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 036900/0216 →
Merger and Change of Name
Feb 26, 2019
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.; ALBERT EINSTEIN COLLEGE OF MEDICINE
To: ALBERT EINSTEIN COLLEGE OF MEDICINE
Reel/Frame 048438/0275 →
Release of Security Interest
Dec 16, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
Reel/Frame 054774/0446 →
Security Interest
Dec 17, 2020
From: BIOCRYST PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Reel/Frame 054800/0634 →
Release of Security Interest
Apr 6, 2023
From: MIDCAP FINANCIAL TRUST
To: BIOCRYST PHARMACEUTICALS, INC.; MDCP, LLC
Reel/Frame 063348/0762 →
Release of Grant of Security Interest in Patents
Apr 18, 2023
From: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 063362/0550 →